Validity and Inter-Rater Reliability of a Novel Bedside Referral Tool for Spasticity
NCT03209960 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2018-10-09
Summary
The purpose of this study is to improve spasticity diagnosis through development of a simple physical examination guide for primary care providers to identify patients who would benefit from being referred to a movement disorders neurologist for a spasticity evaluation.
Conditions
- Spasticity, Muscle
- Muscular Diseases
- Musculoskeletal Disease
- Muscle Hypertonia
- Muscle Spasticity
- Neuromuscular Manifestations
- Signs and Symptoms
- Nervous System Diseases
- Neurologic Manifestations
Interventions
- DIAGNOSTIC_TEST
-
Bedside Referral Tool
Two Vanderbilt primary care providers (a nurse practitioner and a primary care physician) will examine all consented residents. Each primary care provider will perform elements of a physical exam guided by the bedside referral tool to determine if a referral to a movement disorders neurologist is required for a spasticity consultation.
- OTHER
-
Neurological Examination
The subject will undergo elements of the neurological examination during which the movement disorders neurologist will look specifically for the presence of spasticity. If spasticity is found to be present during the examination, the neurologist will rate the severity of the spasticity in all affected limbs and record whether they would recommend treatment for spasticity, and if so, which treatment(s) they believe would be beneficial for the subject.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
David Charles, M.D. · Professor and Vice-Chairman of Neurology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-01-30
- Primary Completion
- 2018-08-01
- Completion
- 2018-08-01
Countries
- United States
Study Locations
More Related Trials
-
Efficacy and Safety Dose Titration Study of Botulinum Toxin Type A to Treat Spasticity in the Leg and Arm
NCT01603459 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Arm After a Stroke
NCT01392300 ·Status: COMPLETED ·Phase: PHASE3
-
Telemedicine Follow-up for Patients With Cervical Dystonia Treated With Neurotoxin Injections
NCT03969537 ·Status: COMPLETED
-
Neurotoxin and Physical Therapy
NCT02177617 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
NCT00651690 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Efficacy of Spasticity-correcting Surgery and Botulinum Toxin Injections for Upper Limb Spasticity Treatment
NCT03910101 ·Status: COMPLETED ·Phase: NA
-
Quantifying Muscle Tone in Patients With Brain Injury - a Feasibility Study
NCT04207632 ·Status: UNKNOWN
-
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
NCT00133861 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral Palsy
NCT00250081 ·Status: TERMINATED ·Phase: NA
-
Central Effects of Botulinum Toxin: Neurophysiological Study in Stroke Patients With Spastic Lower Limb
NCT01829763 ·Status: UNKNOWN ·Phase: PHASE3
-
Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
NCT00819065 ·Status: COMPLETED ·Phase: PHASE3
-
Vanderbilt University Spasticity Management Program Evaluation Plan
NCT00179114 ·Status: COMPLETED ·Phase: PHASE4
-
Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients
NCT02390206 ·Status: COMPLETED
-
Exploring Advanced Imaging Techniques to Characterize Botulinum Toxin Diffusion in Human Muscle
NCT01412008 ·Status: COMPLETED ·Phase: NA
-
Early Treatment of Post-stroke Spasticity With Botulinum Toxin
NCT04404868 ·Status: COMPLETED
-
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
NCT05103202 ·Status: COMPLETED
-
Study Evaluating Treatment of Upper Limb Spasticity Using the Cryo-Touch III Device
NCT01863901 ·Status: COMPLETED ·Phase: NA
-
Imaging of 3D Innervation Zone Distribution in Spastic Muscles From High-density Surface EMG Recordings
NCT03302741 ·Status: COMPLETED ·Phase: PHASE4
-
Radiosurgery Treatment for Spasticity Associated With Stroke, SCI & Cerebral Palsy
NCT06070233 ·Status: RECRUITING ·Phase: NA
-
An Observational Study of Individuals With Isolated Dystonia
NCT07111663 ·Status: RECRUITING
-
CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY
NCT04673240 ·Status: UNKNOWN
-
Relation Between Dose and Time to Reinjection of Botulinum Toxin-A in Patient With Poststroke Spasticity From a Real-world Healthcare Insurance Database.
NCT04649632 ·Status: COMPLETED
-
Spastic Cocontractions and Limitation of Active Movements Before and After Treatment During Injection of Botulinum Toxin
NCT03453008 ·Status: UNKNOWN
-
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury
NCT03992404 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia
NCT02604186 ·Status: COMPLETED ·Phase: PHASE2/PHASE3